Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ActivePassive International Equity ETF
(NY:
APIE
)
36.04
+0.11 (+0.31%)
Official Closing Price
Updated: 5:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
30,284
Open
35.97
Bid (Size)
17.73 (100)
Ask (Size)
54.35 (100)
Prev. Close
35.93
Today's Range
35.97 - 36.18
52wk Range
26.18 - 36.86
Shares Outstanding
257,750
Dividend Yield
1.66%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Ryanair Pulls Plug On Prime Membership Offering After Trial Proves Too Costly
↗
November 28, 2025
Via
Stocktwits
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study
↗
November 25, 2025
Via
Stocktwits
Performance
YTD
+28.8%
+28.8%
1 Month
+0.1%
+0.1%
3 Month
+6.6%
+6.6%
6 Month
+11.2%
+11.2%
1 Year
+22.9%
+22.9%
More News
Read More
Novo Nordisk’s Blockbuster Drug Fails To Slow Alzheimer’s Disease Progression In Studies
↗
November 24, 2025
Via
Stocktwits
Why Did BioNTech Stock Surge 10% Pre-Market Today?
↗
September 05, 2025
Via
Stocktwits
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More
↗
September 04, 2025
Via
Stocktwits
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report
↗
July 11, 2025
Via
Stocktwits
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants
↗
July 08, 2025
Via
Stocktwits
Topics
Death
Government
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullish
↗
July 03, 2025
Via
Stocktwits
US Judge Upholds FDA Decision To Remove Wegovy, Ozempic From Shortage List In Move Against Compounding Pharmacies
↗
June 18, 2025
Via
Stocktwits
Topics
Lawsuit
Novo Nordisk’s Plan To Start Late-Stage Trial Of Investigational Obesity Drug Amycretin In 2026 Gets Retail Talking
↗
June 12, 2025
Via
Stocktwits
Mesoblast Gives Positive Update About Potential FDA Application For Heart Failure Therapy: Retail Sees ‘Inflection Point’
↗
June 12, 2025
Via
Stocktwits
Novo Nordisk’s $812M Deal With Deep Apple Lifts Retail Mood, Chatter Spikes To High Levels
↗
June 11, 2025
Via
Stocktwits
Topics
Artificial Intelligence
Economy
WeRide Partners With Renault To Provide Autonomous Shuttle At The French Open, But Retail’s Not Excited
↗
June 03, 2025
Via
Stocktwits
Topics
Artificial Intelligence
Roche Gets Positive Opinion For Approval Of Cancer Therapy In EU: Retail Yet To React
↗
May 23, 2025
Via
Stocktwits
Topics
Government
Novo Nordisk To Sell Wegovy For $199 A Month As Compounding Ban Nears: Retail’s Bullish
↗
May 22, 2025
Via
Stocktwits
WeRide Narrows Losses In Q1, Announces $100M Share Repurchase Program: Retail’s Thrilled
↗
May 21, 2025
Via
Stocktwits
Novo Nordisk CEO Lars Jørgensen Steps Down Amid Challenges, Retail Chatter Spikes
↗
May 16, 2025
Via
Stocktwits
Tencent Revenue Tops Forecasts On Gaming Surge, AI Ad Gains As Stock Rallies
↗
May 14, 2025
Via
Stocktwits
Topics
Artificial Intelligence
Earnings
Novo Nordisk Stock Rises Pre-Market On Q1 Beat Despite Lowering Outlook – Retail’s Elated
↗
May 07, 2025
Via
Stocktwits
Topics
Earnings
Law Enforcement
Novo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast Asia
↗
April 28, 2025
Via
Stocktwits
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
↗
April 25, 2025
Via
Stocktwits
Topics
Lawsuit
BYD Doubles Profit In Q1 2025 Driven By Strong Growth In Vehicle Sales: But Retail’s Unconvinced
↗
April 25, 2025
Via
Stocktwits
Saudi Aramco To Collaborate With Chinese EV Giant BYD To Achieve Breakthroughs In New Energy Vehicles
↗
April 21, 2025
Via
Stocktwits
Topics
Economy
Electric Vehicles
Government
Novo Nordisk Warns Against Counterfeit Ozempic In US: Retail’s Unmoved
↗
April 14, 2025
Via
Stocktwits
Topics
Economy
Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays Bullish
↗
April 02, 2025
Via
Stocktwits
Frequently Asked Questions
Is ActivePassive International Equity ETF publicly traded?
Yes, ActivePassive International Equity ETF is publicly traded.
What exchange does ActivePassive International Equity ETF trade on?
ActivePassive International Equity ETF trades on the New York Stock Exchange
What is the ticker symbol for ActivePassive International Equity ETF?
The ticker symbol for ActivePassive International Equity ETF is APIE on the New York Stock Exchange
What is the current price of ActivePassive International Equity ETF?
The current price of ActivePassive International Equity ETF is 36.04
When was ActivePassive International Equity ETF last traded?
The last trade of ActivePassive International Equity ETF was at 11/28/25 05:00 PM ET
What is the market capitalization of ActivePassive International Equity ETF?
The market capitalization of ActivePassive International Equity ETF is 9.29M
How many shares of ActivePassive International Equity ETF are outstanding?
ActivePassive International Equity ETF has 9M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.